Navigation Links
Angiotech announces results for the fourth quarter ended December 31, 2007
Date:2/14/2008

ty resources to execute our various research, product development and growth initiatives in 2008.

Our financial outlook is provided to give investors an assessment of our expected financial results and our future business, and may not be appropriate for any other purposes. Given the risks, uncertainties and assumptions associated with such information, readers are cautioned not to place undue reliance on our financial outlook. Except as required by law, we disclaim any obligation to update our financial outlook.

Financial Information

---------------------

This press release contains the condensed financial information derived from the preliminary unaudited interim consolidated financial statements for the three month periods ended December 31, 2007 and 2006, and preliminary unaudited consolidated financial statements for the years ended December 31, 2007 and 2006 as previously reported. The unaudited financial information presented should be considered preliminary and is subject to potential adjustments, including, but not limited to, potential adjustments to certain tax related items, pending the conclusion of the 2007 year-end audit. Upon completion of the 2007 year-end audit process and the approval of our full year 2007 audited consolidated financial statements by our Board of Directors, full audited consolidated financial statements and Management's Discussion and Analysis for the three years ended December 31, 2007, will be filed with the relevant regulatory agencies, as well as posted on our website at http://www.angiotech.com.

We completed the acquisition of the operations of American Medical Instruments Holdings, Inc. ("AMI") on March 23, 2006. Because of the timing of the AMI acquisition, our operating results for the twelve month period ended December 31, 2006 include AMI's results of operations from the period of March 24, 2006 to December 30, 2006, as compared to the
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)NEW YORK, Dec. 4 Stemline Therapeutics, Inc. today announced that data from pre-clinical studies of its IL-3R targeting agents, SL-401 and SL-501, in both in vitro and animal models of human chroni
(Date:12/3/2009)MELVILLE, N.Y., Dec. 3 Nikon Corporation, an innovator of advanced optical instruments, announced today that it has signed a licensing agreement with Harvard University granting Nikon the rights to u
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)HOPKINTON, Mass., Dec. 3 Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 softwa
Breaking Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Caliper Life Sciences Launches Living Image(R) 4.0 Software 2
...to DEMOletter readers to raise enough money and pr...ictims and volunteers of Hurricane Katrina. I,m de...ones are on their way to Houston, and by early thi...em most. , ,The phones are being sent to Care for...essential social services to the elderly, disabled...
...ster for the Oct. 19-20 Wisconsin Early Stage Symp...pare to seek private equity at the state, regional...ools for Commercialization Success" will be held O...Madison ,s Monona Terrace Convention Center . Comp...art in the 8:30 a.m. to 3:30 p.m. venture seminar ...
...nt corporations, chambers of commerce and other or... Entrepreneur (I&E) Club in their areas may now a...trepreneurs, Network (WEN). , ,"I,m confident tha...ntors and entrepreneurs with good ideas can create...artment of Commerce Secretary Mary P. Burke. "We,v...
Other Biology Technology:Readers respond to Katrina Phone Project 2Readers respond to Katrina Phone Project 3Early Stage Symposium session will help emerging companies prepare for investors 2
(Date:12/4/2009)UVALDE Dr. Daniel Leskovar, a Texas AgriLife Research plant physiologist at the Texas AgriLife Research and Extension Center in Uvalde, has been investigating ways to help vegetable plants make a les
(Date:12/4/2009)Scientists from the Royal Botanic Gardens, Kew and the Natural History Museum believe that carnivorous behaviour in plants is far more widespread than previously thought, with many commonly grown plan
(Date:12/4/2009)Using a new mathematical model of heart cells, University of Iowa investigators have shown how activation of a critical enzyme, calmodulin kinase II (CaM kinase), disrupts the electrical activity of h
Breaking Biology News(10 mins):Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4Scientists think 'killer petunias' should join the ranks of carnivorous plants 2U-Iowa study helps advance heart-related research 2Study reveals new role of vitamin C in skin protection 56591 1Study reveals new role of vitamin C in skin protection 56591 2Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 1Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 2Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 3Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 4Dung of the devil plant roots point to new swine flu drugs 9841 1
... 2008 Fifty-nine leading life scientists from Eur...the European Molecular Biology Organization (EMBO)...e of the researchers, distinguished as EMBO Member...le eight equally respected scientists come from ot...rs, bringing the current membership total to 1360....
...sts at the University of Idaho currently are invol...to have been running rampant for the past decade. ...Most Wanted list. Instead, it,s on the minds of ec...ame is Batrachochytrium dendrobatidis (Bd). It i... of protein found in the skin of amphibians, and i...
...the southern coast of Baja California, Mexico, sci...ered sea turtles for a decade as part of an effort... turtle populations. Their findings, published thi...e found dead along a 27-mile stretch of coast duri...y Hoyt Peckham, a graduate student at the Universi...
Other Biology News:EMBO honors 59 leading life scientists 2Modern genetics vs. ancient frog-killing fungus 2Modern genetics vs. ancient frog-killing fungus 3Study finds high mortality of endangered loggerhead sea turtles in Baja California 2
Rabbit Anti-CUGBP2 Monoclonal Antibody, Unconjugated, Clone PADZMD.495 from Invitrogen
UltraClean GelSpin Kit from Mo Bio Laboratories, Inc.
Mouse Anti-Human Melanoma gp100 Monoclonal Antibody, Unconjugated, Clone SPM142 from ABR-Affinity BioReagents
Rat Anti-Human CD66 acd Monoclonal Antibody, Unconjugated, Clone YTH71.3 from GeneTex
Biology Products: